Evaluating osteoporosis and its hormonal determinants in diabetic men: insights from a tertiary care setting in Pakistan
Article Sidebar
Main Article Content
Abstract
Objective: To evaluate the frequency of osteoporosis in male population with diabetes mellitus and to determine the association of osteoporosis with body mass index (BMI), smoking status, and gonadal status.
Methods: This cross-sectional study was conducted at Lady Reading Hospital, Peshawar-Pakistan, from March 2023 to August 2023 with a sample size of 292 male diabetic participants. The sampling was done by non-probability convenient sampling. The inclusion criteria were diabetic male patients aged 25-80 years, whereas patients who were on corticosteroids and diagnosed cases of chronic heart failure, chronic kidney disease, respiratory failure, malignancy, connective tissue disorders, and fracture in the past 6 months were excluded from the study. Bone density and testosterone level were measured. The associations between descriptive data (age, gender, BMI, and gonadal status) and bone density were analyzed.
Results: Out of 292 male diabetic participants with a mean age of 54.41 ± 8.71 years, 203 (69%) were smokers, 136 (47%) were overweight, 23 (7.8%) were obese, while 170 (58.2%) patients were having lower testosterone levels. Bone mineral density levels, measured with Dexa-Scan, demonstrated high frequency of osteoporosis in 120 (41.4 %) patients, and osteopenia in 106 (36.2 %) cases. Chi square statistics showed a significant association of osteoporosis with testosterone (p=0.001) and FSH levels (p=0.01) while such association was not significant with smoking status (p=0.2), LH level (p= 0.8) and BMI (p=0.1).
Conclusion: High frequency of osteoporosis is a concern among the diabetic male population which is positively associated with hypogonadism, warranting early hormonal screening and intervention.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Work published in KMUJ is licensed under a
Creative Commons Attribution 4.0 License
Authors are permitted and encouraged to post their work online
(e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
1. Lorentzon M, Cummings SR. Osteoporosis: the evolution of a diagnosis. J Intern Med 2015;277(6):650–61. https://doi.org/10.1111/joim.12369
2. Compston J. Osteoporosis: social and economic impact. Radiol Clin 2010; 48(3):477–82. https://doi.org/10.1016/j.rcl.2010.02.010
3. Adams JE. Advances in bone imaging for osteoporosis. Nat Rev Endocrinol 2013;9(1):28–42. https://doi.org/10.1038/nrendo.2012.217
4. Wong SK, Chin KY, Suhaimi FH, Ahmad F, Ima-Nirwana S. The relationship between metabolic syndrome and osteoporosis: a review. Nutrients 2016;8(6):347. https://doi.org/10.3390/nu8060347
5. Chin KY, Ng BN, Rostam MKI, Muhammad Fadzil NFD, Raman V, Mohamed Yunus F, et al. A mini review on osteoporosis: From biology to pharmacological management of bone loss. J Clin Med 2022;11(21):6434. https://www.mdpi.com/2077-0383/11/21/6434
6. Issa C, Zantout MS, Azar ST. Osteoporosis in men with diabetes mellitus. J Osteoporos 2011;2011:651867. https://doi.org/10.4061/2011/651867
7. Abdulameer SA, Sahib MN, Sulaiman SAS. The prevalence of osteopenia and osteoporosis among Malaysian type 2 diabetic patients using quantitative ultrasound densitometer. Open Rheumatol J 2018;12:50-64. https://doi.org/10.2174/1874312901812010050
8. Sealand R, Razavi C, Adler RA. Diabetes mellitus and osteoporosis. Curr Diab Rep 2013;13:411–8. https://doi.org/10.1007/s11892-013-0376-x
9. Nielson CM, Marshall LM, Adams AL, LeBlanc ES, Cawthon PM, Ensrud K, et al. BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS). J Bone Miner Res 2011;26(3):496–502. https://doi.org/10.1002/jbmr.235
10. Piñar-Gutierrez A, García-Fontana C, García-Fontana B, Muñoz-Torres M. Obesity and bone health: a complex relationship. Int J Mol Sci 2022;23(15):8303. https://doi.org/10.3390/ijms23158303
11. Ma L, Oei L, Jiang L, Estrada K, Chen H, Wang Z, et al. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol 2012;27(5):319–32. https://doi.org/10.1007/s10654-012-9674-x
12. Hesari E, Sanjari M, Mansourzadeh MJ, Fahimfar N, Khalagi K, Ghazbani A, et al. Osteoporosis medication adherence tools: a systematic review. Osteoporos Int 2023;34(9):1535–48. https://doi.org/10.1007/s00198-023-06789-5
13. von Muhlen D, Safii S, Jassal SK, Svartberg J, Barrett-Connor E. Associations between the metabolic syndrome and bone health in older men and women: The Rancho Bernardo Study. Osteoporos Int 2007;18(10):1337-44. https://doi.org/10.1007/s00198-007-0385-1
14. Gielen E, Vanderschueren D, Callewaert F, Boonen S. Osteoporosis in men. Best Pract Res Clin Endocrinol Metab 2011;25(2):321–35. https://doi.org/10.1016/j.beem.2010.08.012
15. Schousboe JT, Tanner SB, Leslie WD. Definition of osteoporosis by bone density criteria in men: effect of using female instead of male young reference data depends on skeletal site and densitometer manufacturer. J Clin Densitom 2014;17(2):301-6. https://doi.org/10.1016/j.jocd.2013.09.008
16. Mekala KC, Bertoni AG. Chapter 4 - Epidemiology of diabetes mellitus. Transplant Bioeng Regen Endocr Pancreas 2020;Volume 1;29-58. http://doi.org/10.1016/B978-0-12-814833-4.00004-6
17. Mohamad NV, Soelaiman IN, Chin KY. A concise review of testosterone and bone health. Clin Interv Aging 2016;11:1317–24. https://doi.org/10.2147/cia.s115472
18. Golds G, Houdek D, Arnason T. Male hypogonadism and osteoporosis: the effects, clinical consequences, and treatment of testosterone deficiency in bone health. Int J Endocrinol 2017;2017:4602129. https://doi.org/10.1155/2017/4602129
19. El-Desouki MI, Sulimani RA. High prevalence of osteoporosis in Saudi men. Saudi Med J 2007;28(5):774.
20. Salari N, Ghasemi H, Mohammadi L, Behzadi MH, Rabieenia E, Shohaimi S, et al. The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg 2021;16(1):609. https://doi.org/10.1186/s13018-021-02772-0
21. Sadat-Ali M, Al-Habdan IM, Al-Turki HA, Azam MQ. An epidemiological analysis of the incidence of osteoporosis and osteoporosis-related fractures among the Saudi Arabian population. Ann Saudi Med 2012;32(6):637–41. https://doi.org/10.5144/0256-4947.2012.637
22. Agrawal NK, Sharma B. Prevalence of osteoporosis in otherwise healthy Indian males aged 50 years and above. Arch Osteoporos 2013;8(1–2):116. https://doi.org/10.1007/s11657-012-0116-x
23. Abbas SS, Baig S, Rafi S, Farooq W, Niyaz A, Amber SA. Osteoporosis and its association with testosterone levels in males in Pakistani population. Pak J Med Dent 2018;7(4):3–7.
24. Fahimfar N, Noorali S, Yousefi S, Gharibzadeh S, Shafiee G, Panahi N, et al. Prevalence of osteoporosis among the elderly population of Iran. Arch Osteoporos 2021;16:1–10. https://doi.org/10.1007/s11657-020-00872-8